Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease
Year: 2018
Type: article
Authors: Paul M Ridker, Jean G. MacFadyen, Robert J. Glynn, Wolfgang Koenig, Peter Libby, Brendan M. Everett, Martin Lefkowitz, Tom Thuren, Jan H. Cornel
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: canakinumab, IL-1β inhibition, chronic kidney disease, major adverse cardiovascular events, NLRP3 inflammasome, high-sensitivity C-reactive protein, post-infarction patients, atherosclerosis, renal function, albuminuria, inflammation, kidney disease, cardiovascular mortality, stroke, myocardial infarction, diabetes mellitus
Open Access status: bronze
OpenAlex ID: W2803976987
